Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

Improving protocols for protein mapping through proper comparison to crystallography data.

Katrina W Lexa1, Heather A Carlson

  • 1Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, Michigan 48109-1065, USA.

Journal of Chemical Information and Modeling
|January 19, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A workflow to create a high-quality protein-ligand binding dataset for training, validation, and prediction tasks.

Digital discovery·2025
Same author

A Workflow to Create a High-Quality Protein-Ligand Binding Dataset for Training, Validation, and Prediction Tasks.

ArXiv·2025
Same author

Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases.

Journal of medicinal chemistry·2024
Same author

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic.

Cell·2024
Same author

Author Correction: CD98hc is a target for brain delivery of biotherapeutics.

Nature communications·2023
Same author

CD98hc is a target for brain delivery of biotherapeutics.

Nature communications·2023
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same journal

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
See all related articles

Mixed-solvent molecular dynamics (MixMD) accurately identifies protein binding sites by comparing simulations to experimental data. This refined method optimizes simulation parameters for robust application to new drug targets.

Area of Science:

  • Computational chemistry and structural biology.
  • Application of molecular dynamics simulations in drug discovery.

Background:

  • Fragment-based drug design (FBDD) relies on identifying protein "hot spots" for ligand binding.
  • Current computational methods often over-rely on crystallographic coordinates, neglecting experimental electron density.
  • This reliance on coordinates can lead to inaccuracies, especially for novel systems lacking known binding sites.

Purpose of the Study:

  • To refine mixed-solvent molecular dynamics (MixMD) for accurate protein binding site identification.
  • To investigate the influence of protic solvents on simulation accuracy.
  • To establish an optimal MixMD strategy applicable to systems without pre-defined binding sites.

Main Methods:

  • Mixed-solvent molecular dynamics (MixMD) simulations were performed, focusing on protic solvent effects.

More Related Videos

Microcrystallography of Protein Crystals and In Cellulo Diffraction
09:35

Microcrystallography of Protein Crystals and In Cellulo Diffraction

Published on: July 21, 2017

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
09:31

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase

Published on: September 26, 2020

Related Experiment Videos

Last Updated: May 15, 2026

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on: July 5, 2018

Microcrystallography of Protein Crystals and In Cellulo Diffraction
09:35

Microcrystallography of Protein Crystals and In Cellulo Diffraction

Published on: July 21, 2017

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
09:31

PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase

Published on: September 26, 2020

  • Simulations were validated by comparison against experimental crystallographic electron density.
  • Optimization involved determining the most efficient simulation length and number of runs.

    • Main Results:

    • The refined MixMD approach accurately identifies protein active sites by comparing simulations to experimental density.
    • An optimal simulation strategy, considering simulation length and run count, was established.
    • Results demonstrated strong consistency between MixMD simulations and experimental data.

    Conclusions:

    • MixMD provides a robust computational method for identifying protein binding sites, complementing experimental FBDD.
    • The refined method is suitable for diverse target structures, including those with unknown binding sites.
    • Consistency between simulations and electron density can aid in distinguishing probes from water molecules in crystallographic refinement.